Sanara MedTech Inc. (SMTI)
| Bid | 29.51 |
| Market Cap | 277.39M |
| Revenue (ttm) | 86.67M |
| Net Income (ttm) | -9.66M |
| EPS (ttm) | -1.14 |
| PE Ratio (ttm) | -27.38 |
| Forward PE | -12.37 |
| Analyst | Strong Buy |
| Ask | 33 |
| Volume | 10,890 |
| Avg. Volume (20D) | 25,050 |
| Open | 30.53 |
| Previous Close | 30.22 |
| Day's Range | 30.60 - 31.70 |
| 52-Week Range | 25.86 - 39.08 |
| Beta | 1.47 |
About SMTI
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate matur...
Analyst Forecast
According to 2 analyst ratings, the average rating for SMTI stock is "Strong Buy." The 12-month stock price forecast is $48.5, which is an increase of 55.40% from the latest price.
Stock Forecasts
2 months ago · seekingalpha.com
Sanara MedTech: A Promising Growth Story At An Attractive ValuationShares have risen nearly 15% since the company posted preliminary Q4 results, which showed revenue up by 45-48% year over year. While growth was boosted by one-off demand for its BIASURGE product, und...